Rinvoq-45mg (Upadacitinib Tablet) 45mg

Rinvoq 45mg tablets contain upadacitinib and are used to help manage inflammatory conditions. This prescription treatment is taken orally and requires careful monitoring. Always follow your healthcare provider’s guidance when using Rinvoq.

Strength

45mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

AbbVie Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Upadacitinib 45mg tablets are used to reduce inflammation and manage symptoms in certain autoimmune conditions. This medication helps relieve joint pain, swelling, and stiffness associated with rheumatoid arthritis. It is also used to treat other inflammatory conditions as prescribed by a doctor.

Side Effects

Rinvoq 45mg tablets may help reduce inflammation and improve symptoms over time. Users often report less joint pain and improved mobility. Effects vary by individual and may take several weeks to become noticeable.

Precautions & Warnings

Store Rinvoq 45mg tablets at room temperature away from moisture and heat. Keep out of reach of children and pets. Inform your healthcare provider about any ongoing medical conditions or medications before starting treatment.

Avoid Interactions

Rinvoq may interact with other medications, including certain immunosuppressants and blood thinners. Avoid grapefruit products while taking this medication. Always consult your doctor before combining Rinvoq with other treatments.

Frequently Asked Questions

Rinvoq 45mg is used to treat inflammatory conditions like rheumatoid arthritis.

Store Rinvoq 45mg tablets at room temperature in a dry place.

Consult your doctor before combining Rinvoq with other treatments.

Effects may take several weeks to become noticeable.

No, Rinvoq 45mg is not classified as a controlled substance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.